Maiwald Magazine

News and Releases

Maiwald Blog

26 May 2025 - Maiwald Blog

Turn one into several – what Rule 80 EPC says about using several independent claims to defend one independent claim

The Board of Appeal of the EPO has issued two decisions concerning appeal cases T 0123/22 and T 1191/22, which relate to the interpretation of Rule 80 EPC. The fundamental que...

Continue reading

11 Apr 2025 - Maiwald Blog

EPO Board of Appeal 3.3.04 is setting the right standard for acknowledging novelty of non-medical use claims (T 1913/21)

G 2/88 provides legal assessment for novelty of a non-medical use claim. G 2/88 allows acknowledging novelty of a non-medical use claim of an old compound for a particular pur...

Continue reading

8 Apr 2025 - Maiwald Blog

EPO revokes Roche’s Patent on combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer that was supported by results of Phase III AURELIA clinical trial

European Patent EP 2 825 558 concerns a combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer. The claim was supported by Phase III AURELIA c...

Continue reading

All articles

Press Coverage

14 Jul 2025 - Press Coverage

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Continue reading

9 Jul 2025 - Press Coverage

EP 3 996 688 Maintained as Granted: Maiwald successfully defends Formulation Patent for Tepotinib

We are happy to report that we successfully defended Merck’s formulation patent EP 3 996 688 for c-Met inhibitor Tepotinib (TEPMETKO®) in opposition proceedings at the hearing on July 9, 2025. The patent is upheld as granted.

Continue reading

24 Jun 2025 - Press Release

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Continue reading

Maiwald in the press

Staff News

30 Jul 2025 - Staff News

Marvin Bäumel sworn in as German patent attorney

We are pleased to announce that our colleague,

Continue reading

1 Jul 2025 - Staff News

Maiwald appoints Alexander Feil, Dr. Johannes Scholz and Dr. Fabian Wiescher as Counsel

With effect from 1 July 2025, Maiwald, one of Germany's leading intellectual property law firms, has appointed Alexander Feil, Dr. Johannes Scholz and Dr. Fabian Wiescher as C...

Continue reading

20 Jun 2025 - Staff News

Dr. Patrick Heeger and Dr. Andre Mähringer sworn in as German patent attorneys

Congratulations to our colleagues, Dr. Patrick Heeger and

Continue reading

All Staff News

Publications

18 Jul 2025 - Publication

EU regulation on plants from new genomic techniques: green shoots of progress? ManagingIP 2025

In a specialist article, Kerstin Wolff analyzes the current state of EU regulation on new genomic techniques (NGTs). In February 2024, the European Parliament proposed exempti...

Continue reading

11 Jun 2025 - Publication

Managing IP Awards interview: Maiwald
ManagingIP June 10, 2025

In their recent feature with Managing IP, senior representatives from Maiwald – Dr. Anja Fux, Dr. Derk Vos, Heike Roeder-Hitschke, Dr. Nils Braun and Martina Boidol...

Continue reading

30 Apr 2025 - Publication

Safe Harbor Provision in European Patent LawThe Research & Bolar Exemptions, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

This article covers the most recent developments regarding the European Research Exemption, which permits the use of patented inventions for research purposes, as well as the ...

Continue reading

All publications

Awards

23 Jul 2025 - Award

Maiwalds IP Stars & Notable Practitioners 2024 by Managing IP

Maiwald has once again been listed in this year's IP Star Awards by IP Stars by Managing IP (MIP). The IP Stars are experienced practitioners who have been recommended or iden...

Continue reading

30 Jun 2025 - Award

2025 IP Stars Patent Rankings in the categories “Patent Prosecution” and “Patent Disputes” revealed

We are delighted to have been honoured once again by Managing IP (MIP) as a "Top Tier Firm" in the 2025 IP Stars Patent Ranking. With awards in the categories of "Patent Prose...

Continue reading

25 Jun 2025 - Award

Dr. Marco Stief honoured as Thought Leader Germany, Lexology Index 2025

We are delighted that our colleague Dr. Marco Stief has once again been recognized as one of the leading practionee...

Continue reading

All awards

Events

Mon.

22

22 Sep 2025 |Upcoming|External Events

Maiwald at the Munich IP Forum 2025

On 22 and 23 September 2025, the Munich IP Forum will take place at the Rosewood Hotel in Munich – an international conference for decision-makers in the field of intellectual property. The event brings together representatives from leading companies in industries such as pharmaceuticals, biotechnology, automotive, telecommunications and electronics with IP experts from ...

Continue reading

Sun.

28

28 Sep 2025 |Upcoming|External Events

Maiwald at TMAP 2025 in Berlin, September 28-30, 2025

We are pleased to participate in the INTA Trademark Administrators & Practitioners (TMAP) Meeting 2025 in Berlin. This prestigious event brings together trademark administrators, patent paralegals, young professionals and attorneys working in the field of trademark law.The diverse conference program will cover current developments in trademark law and practical top...

Continue reading

Mon.

13

13 Oct 2025 |Upcoming

Maiwald Platinum Partner at the 2025 Life Sciences Strategy Summit on IP & Exclusivity

We are pleased to announce that Maiwald Intellectual Property will participate as a Platinum Partner at the upcoming Life Sciences Strategy Summit on IP & Exclusivity, taking place in the Infinity Hotel & Conference Resort Munich from 13–15 October 2025.

Continue reading

Wed.

16

16 Jul 2025 |Past Event

Maiwald office trip 2025

This year’s firm outing took the entire Maiwald team to the Adventurecamp Schnitzmühle in Viechtach. Although the weather was somewhat unpredictable, it did nothing to dampen our spirits – quite the opposite: the day was filled with positive energy, exciting activities, and memorable moments. The program included:

Continue reading

All events